Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 4172.00 | 4479.50 | 0.9314 | 0.8463 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 4458.00 | 4479.50 | 0.9952 | 0.9892 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4677.00 | 4479.50 | 1.0441 | 1.0994 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4579.00 | 4479.50 | 1.0222 | 1.0500 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4767.00 | 4479.50 | 1.0642 | 1.1449 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4961.00 | 4479.50 | 1.1075 | 1.2434 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4640.00 | 4479.50 | 1.0358 | 1.0808 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4853.00 | 4479.50 | 1.0834 | 1.1885 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4400.00 | 4479.50 | 0.9823 | 0.9601 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4588.00 | 4479.50 | 1.0242 | 1.0546 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4653.00 | 4479.50 | 1.0387 | 1.0873 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4792.00 | 4479.50 | 1.0698 | 1.1576 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4649.00 | 4479.50 | 1.0378 | 1.0853 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4294.00 | 4479.50 | 0.9586 | 0.9071 |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4573.00 | 4479.50 | 1.0209 | 1.0470 |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 2500.00 | 2418.67 | 2387.00 | 4479.50 | 0.5329 | -0.0147 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 2500.00 | 2418.67 | 4607.00 | 4479.50 | 1.0285 | 1.0641 |
| SK-BR-3 | Etoposide | 10 | uM | 3 | 2500.00 | 2418.67 | 1683.00 | 4479.50 | 0.3757 | -0.3349 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4705.00 | 4479.50 | 1.0503 | 1.1136 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4579.00 | 4479.50 | 1.0222 | 1.0500 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4446.00 | 4479.50 | 0.9925 | 0.9832 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4414.00 | 4479.50 | 0.9854 | 0.9671 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5458.00 | 5959.25 | 0.9159 | 0.6992 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5680.00 | 5959.25 | 0.9531 | 0.8296 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 5000.00 | 4101.40 | 2435.00 | 5959.25 | 0.4086 | -0.6199 |